Last reviewed · How we verify
Controlled Insertion
At a glance
| Generic name | Controlled Insertion |
|---|---|
| Sponsor | Ocular Therapeutix, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects (NA)
- Immediate Restoration of a New Implant With High Primary Stability (NA)
- Clinical Laboratory Evaluation of Chronic Autonomic Failure
- Closed Versus Open Lateral Internal Sphincterotomy for Chronic Anal Fissure (NA)
- Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant (PHASE3)
- Acupuncture for Blood Pressure Fluctuation During Total Laparoscopic Hysterectomy (NA)
- Effect of Local Application of 1% Metformin Gel on Implant Stability and Peri-implant Bone Density: A Randomized Controlled Study (NA)
- Sphenopalatine Ganglion Block for Post-Dural Puncture Headache: A Pilot Randomised Controlled Trial (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Controlled Insertion CI brief — competitive landscape report
- Controlled Insertion updates RSS · CI watch RSS
- Ocular Therapeutix, Inc. portfolio CI